Xiaozheng Chen

466 total citations
17 papers, 326 citations indexed

About

Xiaozheng Chen is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Xiaozheng Chen has authored 17 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Xiaozheng Chen's work include Cancer Immunotherapy and Biomarkers (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immune cells in cancer (3 papers). Xiaozheng Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immune cells in cancer (3 papers). Xiaozheng Chen collaborates with scholars based in China and United States. Xiaozheng Chen's co-authors include Aiqin Gao, Yuping Sun, Yuying Fang, Zijiang Yang, Fang Zhang, Jingnan Wang, Wenjing Shi, Shuyun Wang, Linlin Wang and Yan Zheng and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Experimental Cell Research and Cancer Letters.

In The Last Decade

Xiaozheng Chen

14 papers receiving 321 citations

Peers

Xiaozheng Chen

ONCOL

IMMUN

PRM

Astri Frafjord Norway

Silvia Esposito Italy

Maria McSharry United States

Henrik Aamodt Norway

María Ochoa-de-Olza Spain

Adam B. Sendor United States

Won Seon Bang South Korea

Christian H. Bergsland Norway

Shifeng Yang China

Teming Zhang China

Astri Frafjord Norway

Xiaozheng Chen

111 ×0.8

173 ×1.3

ONCOL

164 ×1.3

IMMUN

97 ×1.3

PRM

80 ×1.1

Citations per year, relative to Xiaozheng Chen Xiaozheng Chen (= 1×) peers Astri Frafjord

Countries citing papers authored by Xiaozheng Chen

Since Specialization

Citations

This map shows the geographic impact of Xiaozheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozheng Chen more than expected).

Fields of papers citing papers by Xiaozheng Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozheng Chen. The network helps show where Xiaozheng Chen may publish in the future.

Co-authorship network of co-authors of Xiaozheng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozheng Chen. A scholar is included among the top collaborators of Xiaozheng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozheng Chen. Xiaozheng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wang, Juan, Songbo Xie, Lisheng Liu, et al.. (2025). ASPM Induces Radiotherapy Resistance by Disrupting Microtubule Stability Leading to Chromosome Malsegregation in Non‐Small Cell Lung Cancer. Exploration. 5(4). e20230024–e20230024. 1 indexed citations

Chen, Xiaozheng, et al.. (2025). The burden of COVID-19 death for different cancer types: a large population-based study. Journal of Global Health. 15. 4046–4046.

Chen, Xiaozheng, et al.. (2024). Unraveling the mechanisms of RECQL4-mediated cervical cancer progression through the PI3K/AKT pathway. Translational Oncology. 50. 102146–102146. 2 indexed citations

Lu, Jie, Hao Li, Xiaozheng Chen, et al.. (2024). The impact of POSTN on tumor cell behavior and the tumor microenvironment in lung adenocarcinoma. International Immunopharmacology. 145. 113713–113713. 2 indexed citations

Wu, Fei, Changyan Xiao, Xiaozheng Chen, et al.. (2023). Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer. Experimental Hematology and Oncology. 12(1). 67–67. 26 indexed citations

Wu, Fei, Zengfu Zhang, Vivek Verma, et al.. (2023). Cellular Atlas of Senescent Lineages in Radiation- or Immunotherapy-Induced Lung Injury by Single-Cell RNA-Sequencing Analysis. International Journal of Radiation Oncology*Biology*Physics. 116(5). 1175–1189. 18 indexed citations

Huang, Yiheng, Minxin Chen, Fei Wu, et al.. (2023). Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade. Journal for ImmunoTherapy of Cancer. 11(8). e007035–e007035. 11 indexed citations

Chen, Xiaozheng, et al.. (2023). [Progress in antitumor activity of diterpenoid alkaloids in plants of Aconitum].. PubMed. 48(14). 3765–3773.

Wang, Shuyun, Yuxiao Song, Fang Zhang, et al.. (2022). Neurturin promotes tumor cell motility and angiogenesis in colorectal cancer. Experimental Cell Research. 413(1). 113049–113049. 9 indexed citations

10.

Zheng, Yawen, Yanan Liu, Fang Zhang, et al.. (2022). Radiation combined with KRAS-MEK inhibitors enhances anticancer immunity in KRAS-mutated tumor models. Translational research. 252. 79–90. 14 indexed citations

11.

Hu, Huimin, Xiaozheng Chen, Yonglan Zhang, & Zhong‐Dong Du. (2022). [Association of liver damage with coronary artery lesion and no response to intravenous immunoglobulin in the acute stage of Kawasaki disease].. PubMed. 24(6). 681–686.

12.

Chen, Xiaozheng, Aiqin Gao, Fang Zhang, et al.. (2021). ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Theranostics. 11(7). 3392–3416. 130 indexed citations

13.

Li, Juan, Aiqin Gao, Fang Zhang, et al.. (2020). ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer. Cancer Letters. 501. 263–276. 41 indexed citations

14.

Li, Juan, Shuyun Wang, Jingnan Wang, et al.. (2020). Overexpressed immunoglobulin-like transcript (ILT) 4 in lung adenocarcinoma is correlated with immunosuppressive T cell subset infiltration and poor patient outcomes. Biomarker Research. 8(1). 11–11. 20 indexed citations

15.

Lin, Wen‐Li, Aiqin Gao, Yanli Liu, et al.. (2019). Forkhead box C1 promotes metastasis and invasion of non–small cell lung cancer by binding directly to the lysyl oxidase promoter. Cancer Science. 110(12). 3663–3676. 17 indexed citations

16.

Lu, Haijiao, Zhuang Yu, Shihai Liu, et al.. (2015). CUGBP1 promotes cell proliferation and suppresses apoptosis via down-regulating C/EBPα in human non-small cell lung cancers. Medical Oncology. 32(3). 82–82. 14 indexed citations

17.

Yu, Zhuang, Xiaozheng Chen, Lianhua Cui, et al.. (2014). Prediction of Lung Cancer Based on Serum Biomarkers by Gene Expression Programming Methods. Asian Pacific Journal of Cancer Prevention. 15(21). 9367–9373. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact